Activity value 72china Buyer&Supplier,Last transaction date:
2026-02-14
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for citral pharma co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 2 transactions, with a transaction quantity of 327.5 and a transaction weight of 0.
YearTransactionsQuantityWeight
20251511303.30
20262327.50
Bill of lading data
<
1/15
>
Trade date
2026/02/14
B/L No.
5000851
Suppliers
citral pharma co.ltd.
Buyers
glenmark pharmaceuticals inc.
POLs
——
PODs
mumbai (ex bombay)
Supply area
China
Purchas area
India
Weight
——
Amount
1012.5
Hs code
29419019
Product tags
clindamycin,phosphate,bat,ospa,api l
Product description
CLINDAMYCIN PHOSPATE BATCH NO P 20250901B CLINDAMYCINPHOSPHATE API LIST 2 SR NO 8 CLINDAMYCIN PHOSPATE BATCH NO P 20250901B
Expand
5ajanta pharma ltd.
united statesbuyer,they trade on 2025-04-17
54.24%
>
+View All
Products
Total 9
ProductsTransactionsPerDetail
clindamycin hydrochloride 1551.72%>
clindamycin phosphate 1034.48%>
amphotericin b 26.9%>
clindamycin 13.45%>
e 200 13.45%>
+View All
Hscode rank
Total 12
HSCode NameTransactionsPerDetail
HS 294190902275.86%>
HS 29419040310.34%>
HS 3004909926.9%>
HS 29419000003926.9%>
Trading Area
Total 5
AreaTransactionsPerDetail
india7664.41%>
turkey1815.25%>
indonesia65.08%>
russia54.24%>
ukraine10.85%>
citral pharma co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as clindamycin hydrochloride,clindamycin phosphate,amphotericin b.
According to the 52wmb.com global trade database, as of 2026-02-14, the company has completed 118 international trades,
with its main trading regions covering india,turkey,indonesia etc.
The core products include HS29419090,HS29419040,HS30049099 etc,
and its main trading partners are trichem healthcare pvt ltd.,vergo pharma research laboratories pvt ltd.,tüm-ekip ilaç anonim şirketi.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on citral pharma co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.